These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7671556)

  • 21. The relationship between obesity, plasma immunoreactive insulin concentration and blood pressure in newly diagnosed Indian type 2 diabetic patients.
    Yajnik CS; Naik SS; Bhat DS; Joshi VM; Shelgikar KM; Alberti KG; Hockaday TD
    Diabet Med; 1993 Mar; 10(2):146-51. PubMed ID: 8458191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copper, zinc, manganese, and magnesium status and complications of diabetes mellitus.
    Walter RM; Uriu-Hare JY; Olin KL; Oster MH; Anawalt BD; Critchfield JW; Keen CL
    Diabetes Care; 1991 Nov; 14(11):1050-6. PubMed ID: 1797486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnesium levels in plasma, erythrocyte, and platelet in hypertensive and normotensive patients with type II diabetes mellitus.
    Corica F; Ientile R; Allegra A; Romano G; Cangemi F; Di Benedetto A; Buemi M; Cucinotta D; Ceruso D
    Biol Trace Elem Res; 1996 Jan; 51(1):13-21. PubMed ID: 8834376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte and plasma magnesium status in Nigerians with diabetes mellitus.
    Olukoga AO; Erasmus RT; Adewoye HO
    Ann Clin Biochem; 1989 Jan; 26 ( Pt 1)():74-7. PubMed ID: 2735750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma and erythrocyte magnesium levels are correlated with oxygen uptake in patients with non-insulin dependent diabetes mellitus.
    Kobayashi T
    Endocr J; 1998 Apr; 45(2):277-83. PubMed ID: 9700483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
    Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
    Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control.
    Schnack C; Bauer I; Pregant P; Hopmeier P; Schernthaner G
    Diabetologia; 1992 Jan; 35(1):77-9. PubMed ID: 1541384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values.
    Guerrero-Romero F; Rodríguez-Morán M
    J Diabetes Complications; 2000; 14(5):272-6. PubMed ID: 11113690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum ionized magnesium in diabetic older persons.
    Barbagallo M; Di Bella G; Brucato V; D'Angelo D; Damiani P; Monteverde A; Belvedere M; Dominguez LJ
    Metabolism; 2014 Apr; 63(4):502-9. PubMed ID: 24462317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered platelet magnesium and plasma and urinary soluble form of intercellular adhesion molecule I (sICAM-1) concentrations in insulin dependent diabetes mellitus (IDDM) patients with microalbuminuria.
    Corica F; Allegra A; Buemi M; Ientile R; Corsonello A; Di Benedetto A; Bonanzinga S; Ruello A; D'Angelo R; Cucinotta D; Ceruso D
    Magnes Res; 1996 Dec; 9(4):307-12. PubMed ID: 9247879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients.
    Trovati M; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Piretto V; Cavalot F; Anfossi G
    Diabetes; 1995 Nov; 44(11):1318-22. PubMed ID: 7589830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidative protein damage in early stage Type 1 diabetic patients.
    Telci A; Cakatay U; Salman S; Satman I; Sivas A
    Diabetes Res Clin Pract; 2000 Dec; 50(3):213-23. PubMed ID: 11106836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus.
    Nadler JL; Malayan S; Luong H; Shaw S; Natarajan RD; Rude RK
    Diabetes Care; 1992 Jul; 15(7):835-41. PubMed ID: 1516501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ca(2+)-Mg(2+)-ATPase activity and ionized calcium in Type 2 diabetic patients with neuropathy.
    Migdalis IN; Xenos K; Chairopoulos K; Varvarigos N; Leontiades E; Karmaniolas K
    Diabetes Res Clin Pract; 2000 Aug; 49(2-3):113-8. PubMed ID: 10963822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin and high glucose modulation of phosphatase and reductase enzymes in the human erythrocytes: a comparative analysis in normal and diabetic states.
    Marques F; Crespo ME; Silva ZI; Bicho M
    Diabetes Res Clin Pract; 2000 Mar; 47(3):191-8. PubMed ID: 10741568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced intraplatelet magnesium concentrations in elderly patients with non-insulin dependent diabetes mellitus (NIDDM).
    Corica F; Allegra A; Ientile R; Buemi M; Corsonello A; D'Angelo R; Bonanzinga S; Cucinotta D; Ceruso D
    Arch Gerontol Geriatr; 1997; 25(3):255-62. PubMed ID: 18653113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated sodium-lithium countertransport activity in erythrocytes is predictive of the development of microalbuminuria in IDDM.
    Monciotti CG; Semplicini A; Morocutti A; Maioli M; Cipollina MR; Barzon I; Palaro C; Brocco E; Trevisan M; Fioretto P; Crepaldi G; Nosadini R
    Diabetologia; 1997 Jun; 40(6):654-61. PubMed ID: 9222644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet free Ca2+ concentration in non-insulin-dependent diabetes mellitus.
    Yamaguchi T; Kadono K; Tetsutani T; Yasunaga K
    Diabetes Res; 1991 Oct; 18(2):89-94. PubMed ID: 1841817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced Na(+)-K(+)-ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients.
    Rabini RA; Galassi R; Fumelli P; Dousset N; Solera ML; Valdiguie P; Curatola G; Ferretti G; Taus M; Mazzanti L
    Diabetes; 1994 Jul; 43(7):915-9. PubMed ID: 8013757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet plasminogen activator inhibitor 1 in patients with type II diabetes.
    Jokl R; Laimins M; Klein RL; Lyons TJ; Lopes-Virella MF; Colwell JA
    Diabetes Care; 1994 Aug; 17(8):818-23. PubMed ID: 7956624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.